
    
      There are 5 dose groups with 8 participants in each group, including 6 participants in the
      experimental group and 2 participants in the placebo control group.

      Since the strength of experimental drug is 150mg/1ml/ bottle, participants with a single dose
      of more than 150mg need to be given subcutaneously at different sites in two or more times
    
  